Galletta Christopher 4
4 · Trevi Therapeutics, Inc. · Filed Feb 15, 2022
Insider Transaction Report
Form 4
Galletta Christopher
See Remarks
Transactions
- Award
Stock Option (right to buy)
2022-02-11+35,000→ 35,000 totalExercise: $0.51Exp: 2032-02-10→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 11, 2022. The 35,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 11, 2023 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 11, 2026.